loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of Drug Master Files (JDMF) for Ambrisentan Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 MSN Laboratories Private Limited. (1)

02 Tateyama Kasei Co., Ltd. (1)

filter

01 Ambrisentan (1)

02 Ambrisentan (1)

filter

01 India (1)

02 Japan (1)

URL Supplier Web Content
302MF10087
Plot No: C-24, Sanath Nagar Industr...
2021-05-10
2020-07-22
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
302MF10090
1133 Oe, Imizu City, Toyama Prefect...
2022-01-11
2020-07-29
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 177036-94-1 / Ambrisentan API manufacturers, exporters & distributors?

Ambrisentan manufacturers, exporters & distributors 1

68

PharmaCompass offers a list of Ambrisentan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ambrisentan manufacturer or Ambrisentan supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ambrisentan manufacturer or Ambrisentan supplier.

PharmaCompass also assists you with knowing the Ambrisentan API Price utilized in the formulation of products. Ambrisentan API Price is not always fixed or binding as the Ambrisentan Price is obtained through a variety of data sources. The Ambrisentan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ambrisentan

Synonyms

177036-94-1, Letairis, Volibris, Lu-208075, Bsf 208075, Bsf-208075

Cas Number

177036-94-1

Unique Ingredient Identifier (UNII)

HW6NV07QEC

About Ambrisentan

Ambrisentan is an orally bioavailable, selective antagonist of the endothelin type-A (ETA) receptor that may be used for the treatment of pulmonary arterial hypertension (PAH). Upon administration, ambrisentan targets and binds to ETA receptor, which prevents the binding of endothelin-1 (ET-1) to the ETA receptor and ET-1/ETA-mediated vasoconstriction and cell proliferation. This may lead to vasodilation. ET-1 concentrations are increased in plasma as well as lung tissue in PAH, and ET-1 may play a key role in the pathogenesis of PAH.

Ambrisentan Manufacturers

A Ambrisentan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ambrisentan, including repackagers and relabelers. The FDA regulates Ambrisentan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ambrisentan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ambrisentan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ambrisentan Suppliers

A Ambrisentan supplier is an individual or a company that provides Ambrisentan active pharmaceutical ingredient (API) or Ambrisentan finished formulations upon request. The Ambrisentan suppliers may include Ambrisentan API manufacturers, exporters, distributors and traders.

click here to find a list of Ambrisentan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ambrisentan JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Ambrisentan Drug Master File in Japan (Ambrisentan JDMF) empowers Ambrisentan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Ambrisentan JDMF during the approval evaluation for pharmaceutical products. At the time of Ambrisentan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Ambrisentan suppliers with JDMF on PharmaCompass.

Ambrisentan Manufacturers | Traders | Suppliers

Ambrisentan Manufacturers, Traders, Suppliers 1
66

We have 2 companies offering Ambrisentan

Get in contact with the supplier of your choice:

  1. MSN Laboratories
  2. TATEYAMA KASEI CO LTD
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY